Company
Board Member
2018-01-01–2024-12-12
Michael Altman
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Michael Altman
The company reported in an 8-K filed December 13, 2024 that Michael Altman resigned as Director, effective December 12, 2024.
“On December 12, 2024, Michael Altman and Konstantin Poukalov each resigned from the Board of Directors (the "Board") of Lyra Therapeutics, Inc., effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Organization not stated
Board Member
Proxy statement
2018-01-01–2024-12-12
-
Organization not stated
Board Member
Proxy statement
2018-01-01–2024-12-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
-
Executive change Resigned: Director